Evidence map›Paper›PMID 31121970›Full record

ArticleGenes2019

Three New Integration Vectors and Fluorescent Proteins for Use in the Opportunistic Human Pathogen

Lance E Keller, Anne-Stéphanie Rueff, Jun Kurushima, Jan-Willem Veening

Open access · goldAbstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Regulation of PBP2x Surface Localization byPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Cleavage ofbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. AliC and AliD of nonencapsulatedFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Expanding the genetic toolbox for the obligate human pathogenFrontiers in bioengineering and biotechnology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. MgaVirulence · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lance E KellerDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland. lanceedward.keller@unil.ch.
Anne-Stéphanie RueffDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland. anne-stephanie.rueff@unil.ch.
Jun KurushimaDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland. jun.kurushima@unil.ch.
Jan-Willem VeeningDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland. Jan-Willem.Veening@unil.ch.
University of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we describe the creation of three integration vectors, pPEPX, pPEPY and pPEPZ, for use with the opportunistic human pathogen

Indexed as

Genetic VectorsGenome, BacterialHumansLuminescent ProteinsOpportunistic InfectionsPlasmidsPneumococcal InfectionsPromoter Regions, GeneticStreptococcus pneumoniaeLuminescent Proteinsexpression vectorsmNeonGreenmScarlet-ImTurquoise2pneumococcal engineering platformStreptococcus pneumoniaesynthetic biology

Identifiers

PMID31121970
PMCPMC6562690
OpenAlexW2935035136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.